A global pharmaceutical company had developed a new vaccine that was nearing launch, and knew they had to maximize patient access at time of launch. This required securing public and private coverage fast. One of the main challenges was that the vaccines business, recently acquired, still operated in isolation from the rest of the company and needed to quickly establish stronger working relationships with key functions like market access, while preserving its unique culture.
Thirty-two people – directors, managers, and senior managers – gathered from across different parts of the organization, from marketing, health education,vaccines, access, regulatory, finance, to policy. Their challenge was to determine how to ensure that patients had optimal access to their novel vaccine at launch.
Together, the team produced a 12-point agenda that covered topics such as disease awareness, integration, customer needs, prioritization & workload. They mapped out scenarios for what would happen if they got the coverage they wanted,if they didn't, and so on. They produced strategic recommendations for coordinating campaigns across brands, for instituting better long-term planning to manage people's workload, and for creating a core team responsible for integrating the vaccines business with the broader human health division.
The team was able to produce a thoughtful plan – in a few days –that pulled together people from multiple businesses to execute rapidly. They were able to secure public and private coverage for the vaccine at unprecedented speed. The vaccine is now widely listed and used worldwide. It’s significant uptake at launch was noticed by global media and experts.
Subscribe for all our latest Forbes articles, whitepapers, and more.